SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending, with community members actively promoting its Telegram, website, and X (Twitter) presence. Some users highlight the coin's association with weed culture and promote the idea that it is "like Bitcoin but way higher", while others are discussing its use at UFC 320.

its a Meme token and beta to Troll The "Lenny face  is a text-based emoticon, ( ͡° ͜ʖ ͡°), used to convey a range of emotions, particularly mischief, sexual innuendo, or a hidden meaning. It's often employed in online discussions to add a playful or suggestive tone to a message, or sometimes even to spam threads, according to Wikipedia. The symbol is visually interpreted as a face with two eyes (small circles), a nose (squiggly line), and a mouth (curved line).

Lenny

$LENNY is trending as community members rally around the 'Lenny Face' meme, emphasizing its cultural significance and long-standing internet presence. Discussions highlight the project's community-driven approach and the 'cult' forming around the token, with holders expressing strong conviction and dismissing concerns of hype. Some community members are drawing comparisons to other meme tokens like $SHIB and focusing on community growth.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPM is trending amid discussions around potential losses from loans to a subprime auto lender, Tricolor, and scrutiny of ties to Jeffrey Epstein. Despite some negative sentiment and options activity suggesting caution, there's also optimism fueled by potential buybacks, a recent dividend hike, and a TD Cowen price target increase. The community is actively debating the bank's valuation, future direction, and potential impact from broader market trends.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as it reaches new all-time highs, sparking excitement and discussions around potential future price targets. The community is actively debating whether this surge is sustainable, with some pointing to increased institutional adoption and limited supply as bullish factors, while others remain cautious, citing potential pullbacks. Many are also referencing the upcoming halving event and its historical impact on price.

KeyCorp is a bank holding company, which engages in the provision of financial services. It operates through the Consumer Bank and Commercial Bank segments. The Consumer Bank segment offers deposit and investment products, personal finance and financial wellness services, lending, mortgage and home equity, student loan refinancing, credit card, treasury services, and business advisory services. The Commercial Bank segment focuses on serving the needs of middle market clients in seven industry sectors, consumer, energy, healthcare, industrial, public sector, real estate, and technology. The company was founded on December 31, 1958 and is headquartered in Cleveland, OH.

Keycorp

KeyCorp ($KEY) is trending due to recent analyst upgrades and raised price targets, sparking community discussion about its potential for growth. Investors are weighing positive factors like its solid dividend yield against regional bank sector headwinds and past challenges. Option activity is mixed, with both bullish and bearish sentiment reflected in unusual put and call flows.

Kimco Realty Corp. is a real estate investment trust company, which engages in the ownership and operation of open-air and grocery-anchored shopping centers. It also specializes in shopping center acquisitions, development and management. The company was founded by Milton Cooper and Martin S. Kimmel in 1973 and is headquartered in Jericho, NY.

Kimco Realty Corporation

Kimco Realty Corp.

Kimco Realty ($KIM) is trending due to a recent credit rating boost and analyst optimism, driving shareholder confidence. Discussions revolve around potential long-term growth and the impact of a grocery-anchored portfolio. Additionally, specific call options are being highlighted as potential short-term plays.

Grayscale Investments LLC - Grayscale Bitcoin Trust

Grayscale Bitcoin Trust

GBTC is trending as the price of Bitcoin nears all-time highs, sparking predictions of further gains and a potential "mini parabolic" move, with some community members anticipating a rise to $100, then $120. Options activity is high, with many traders buying call options, and some suggesting that any dip represents a buying opportunity. The broader context includes discussion around seasonal bullishness for Bitcoin in October and comparisons to other Bitcoin ETFs.

Codatta

Codatta ($XNY) is gaining attention, with community members anticipating a breakout soon. Discussions revolve around its potential to make significant moves, with some traders pointing to a cup and handle formation on the charts and on-chain fingerprint verification launching in September 2025.

Ecolab, Inc. engages in providing products and services in the field of water, hygiene, and energy. It operates through the following segments: Global Industrial, Global Institutional and Specialty, Global Healthcare and Life Sciences, Global Pest Elimination, and Corporate. The Global Industrial segment relates to water, food and beverage, paper, and downstream operating segments. The Global Institutional and Specialty segment refers to the institutional, specialty, and healthcare operating segments. The Global Healthcare and Life Sciences segment includes the healthcare and life sciences operations. The Global Pest Elimination segment provides services designed to detect, prevent and eliminate pests, such as rodents and insects, in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other. The company was founded by Merritt J. Osborn in 1923 and is headquartered in St. Paul, MN.

Ecolab, Inc.

Ecolab is trending amid discussions about potential growth driven by strong demand for cleaning and sanitation solutions, with community members highlighting the company's solid financials and long-term stability. Options activity suggests bullish sentiment, and some analysts have recently raised price targets. The stock is also being discussed in the context of sustainability and water stewardship.

Arbitrum is one of the leading Ethereum scaling solutions bringing cheap transactions to tens of thousands of users in an environment that feels very similar to Ethereum. It is an optimistic rollup and the leading L2 in terms of TVL. Some of the largest dApps live on Arbitrum include GMX, Radiant, Uniswap V3, and Gains Network.

Arbitrum

Arbitrum is trending as discussions center on its potential for growth and real-world asset tokenization, especially with Robinhood utilizing Arbitrum's technology. Community members are weighing bullish sentiment against concerns about token unlocks and dilution. Some traders are closely monitoring order book structures and liquidity traps to make informed decisions.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vera Therapeutics stock sinks following competitor’s successful trial

Investing.com -- Shares of  Vera Therapeutics  (NASDAQ:VERA) tumbled by 33% in premarket trading today after a Japanese competitor, Otsuka, reported positive results from a Phase 3 trial of a competing kidney disease therapy. Otsuka’s announcement indicated that its drug, sibeprenlimab, achieved a 51.2% reduction in proteinuria in the treatment of immunoglobulin A nephropathy (IgAN), surpassing the results from Vera’s own candidate, atacicept.

Shares of Vera Therapeutics, Inc. (VERA) were in the spotlight on Tuesday morning after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.veratx.com/news-releases/news-release-details/vera-therapeutics-announces-refinancing-existing-oxford-debt">announced</a> that it has entered into a new credit facility providing for up to $500 million of term loans with its current partner, Oxford Finance LLC.The new credit facility will replace Vera’s existing $50 million credit facility. The initial funding of the new credit facility will be in a principal amount of $75 million and is expected to occur on June 4, 2025, the company said.The new credit facility features a lower interest rate, increasing capital availability and financial flexibility, the company stated.Vera Therapeutics is looking to submit a Biologics License Application to the U.S. Food and Drug Administration in the fourth quarter of this year for Atacicept. The company is looking forward to the potential commercialization of the investigational drug for the treatment of immunoglobulin A nephropathy (IgAN) in adults.IgA nephropathy, also known as Berger's disease, is a kidney disease where antibodies build up in the kidneys, causing inflammation and damage.Vera on Monday said that Atacicept achieved a 46% reduction from baseline in protein levels in the urine of 431 adults with IgA nephropathy being evaluated in a late-stage trial.VERA stock closed 67% higher on Monday on the news.On Stocktwits, retail sentiment around VERA stayed unmoved within the ‘extremely bullish’ territory over the past 24 hours while message volume remained at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:624/68;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_03_at_8_05_39_AM_png_bf7adee158.webp" alt="VERA's Sentiment Meter and Message Volume as of 8:05 a.m. ET on June 3, 2025 | Source: Stocktwits" width="624" height="68"><figcaption>VERA's Sentiment Meter and Message Volume as of 8:05 a.m. ET on June 3, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user praised the company’s decisions.<stembedurl>https://stocktwits.com/US_Bull/message/616604119</stembedurl>Another expects the stock will hit $40 soon.<stembedurl>https://stocktwits.com/tomf95/message/616602882</stembedurl><a href="https://stocktwits.com/symbol/VERA">VERA stock</a> is down by 25% this year and by about 21% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/weride-partners-with-renault-for-autonomous-shuttle-service-at-the-french-open/chkr56IRbvO">WeRide Partners With Renault To Provide Autonomous Shuttle At The French Open, But Retail’s Not Excited</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Vera Therapeutics Enters $500M Credit Facility As It Nears FDA Filing For Kidney Disease Drug: Retail Sees Stock Touching $40

The new credit facility features a lower interest rate, increasing capital availability and financial flexibility, the company stated.

Equity

The new credit facility features a lower interest rate, increasing capital availability and financial flexibility, the company stated.


Commit To Buy Vera Therapeutics At $25, Earn 12.7% Annualized Using Options

Investors eyeing a purchase of Vera Therapeutics Inc (VERA) shares, but cautious about paying the going market price of 38.14/share, might benefit from considering selling puts among the...

Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress

72-week data of atacicept in IgAN accepted as a best-ranked abstract Analysis of impact of atacicept on hematuria in IgAN accepted as a focused oral presentation BRISBANE, Calif., April 02...

Analysts' Opinions Are Mixed on These Healthcare Stocks: Vera Therapeutics (VERA), Tyra Bioscience (TYRA) and Tenaya Therapeutics (TNYA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vera Therapeutics (VERA Research Report), Tyra Bioscience (TYRA...

Vera Therapeutics reports FY23 EPS ($2.25) vs ($3.35) last year

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Presented positive 72-week data from the Phase 2b ORIGIN clinical trial, setting a new standard in IgAN with no loss of kidney function over the duration of treatmentActively adding sites and...

Vera Therapeutics (VERA, $44.19) Aroon Indicator entered an Uptrend on March 12, 2024.

Over the last three days, A.I.dvisor has detected that VERA's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

Vera Therapeutics (VERA, $43.15) Aroon Indicator entered an Uptrend on March 11, 2024.

Vera Therapeutics (VERA, $44.3) Aroon Indicator entered an Uptrend on March 08, 2024.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

VERA
Vera Therapeutics Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest VERA News

VERA Vera Therapeutics Inc - Ordinary Shares - Class A